British Columbia plans to restrict gross sales of the favored diabetes drug Ozempic to Canadian residents in response to a wave of People flocking to native pharmacies looking for the drug, probably straining provides within the province.
Ozempic, made by Novo Nordisk, is experiencing surging demand as a result of it not solely helps regulate blood sugar in folks with diabetes, however it could actually additionally assist folks shed extra pounds. Within the first two months of this yr, 15% of the roughly 16,000 Ozempic dispenses in British Columbia have been offered to U.S. residents, in line with a Tuesday launch from the province. That’s an “unusually excessive share,” as the typical proportion of different medication offered to People is 0.4%, the province stated.